Cerence Inc. (CRNC) stock
CRNCNasdaqServices-Prepackaged SoftwareFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 9/3012% below fair value
$7.13−0.16 (-2.19%)
Close on Nov 17, 2026Market cap $322.49MP/E –Yield –
Cerence r&d expenses
Research and development expenses are spending on new products and technology.
Cerence's R&D Expenses for the twelve months ending Jun 30, 2026 was $110.64M, up 14.6% year over year. For fiscal 2025 it was $97.76M, down 19.6% from the year before. The highest annual figure on record is $123.33M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $97.76M | -19.6% |
| FY2024 | Sep 30, 2024 | $121.56M | -1.4% |
| FY2023 | Sep 30, 2023 | $123.33M | +15.1% |
| FY2022 | Sep 30, 2022 | $107.12M | -4.4% |
| FY2021 | Sep 30, 2021 | $112.07M | +26.1% |
| FY2020 | Sep 30, 2020 | $88.90M | -4.5% |
| FY2019 | Sep 30, 2019 | $93.06M | +15.0% |
| FY2018 | Sep 30, 2018 | $80.96M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $29.24M | +7.7% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $30.30M | +29.9% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $24.70M | +18.4% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $26.40M | +4.7% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $27.15M | -12.9% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $23.33M | -26.7% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $20.87M | -37.3% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $25.23M | -28.2% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $31.18M | +3.3% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $31.85M | +11.8% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $33.31M | +12.9% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $35.14M | +38.9% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $30.20M | +16.0% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $28.49M | -4.9% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $29.49M | +14.4% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $25.31M | -11.8% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $26.04M | -14.3% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $29.98M | +3.9% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $25.79M | +6.9% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $28.71M | +30.5% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $30.37M | +37.8% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $28.86M | +35.2% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $24.13M | +2.6% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $22.00M | -7.2% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $22.04M | -4.1% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $21.35M | -5.4% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $23.51M | -1.2% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $23.72M | – |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $22.98M | – |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $22.56M | – |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $23.81M | – |
See a number that looks wrong?